Iressa Shows Promise For Treatment Of Metastatic Breast Cancer When Combined With Hormonal Therapy
Friday, May 16, 2008 - 10:21
in Health & Medicine
Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical trial led by researchers.
Read the whole article on Science Daily
More from Science Daily
Related
- Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapyFri, 16 May 2008, 11:22:13 EDT
- Iressa proves just as effective as chemotherapy for lung cancerThu, 20 Nov 2008, 19:32:03 EST
- Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancerThu, 28 May 2009, 17:23:59 EDT
- HER2 levels may aid in treatment selection for metastatic breast cancerTue, 2 Dec 2008, 10:49:47 EST
- Triple drug combination is promising option to treat metastatic HER2+ breast cancerFri, 15 May 2009, 9:36:18 EDT